MLICM
HPTX

Metropolitan Life Insurance Company (MetLife)’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,956
Closed -$503K – 2744
2015
Q1 		$503K Hold
10,956
– – ﹤0.01% 1557
2014
Q4 		$263K Hold
10,956
– – ﹤0.01% 2216
2014
Q3 		$276K Hold
10,956
– – ﹤0.01% 2145
2014
Q2 		$286K Buy
10,956
+3,570
+48% +$91.8K ﹤0.01% 2243
2014
Q1 		$191K Hold
7,386
– – ﹤0.01% 2492
2013
Q4 		$149K Hold
7,386
– – ﹤0.01% 2626
2013
Q3 		$193K Hold
7,386
– – ﹤0.01% 2453
2013
Q2 		$162K Buy
+7,386
New +$162K ﹤0.01% 2498

Metropolitan Life Insurance Company (MetLife)'s HPTX Position: Q2 2015 in Review

Metropolitan Life Insurance Company (MetLife) sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 10,956 shares — an estimated $503K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $503K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 10,956 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $503K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $503K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2015, filed 17 Aug 2015.